Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06971185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept

Name: A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept — clinical trial record (NCT06971185)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhaseNot specified

SponsorBristol-Myers Squibb

Started2024-11-22

View on ClinicalTrials.gov ↗

Amendment history

2026-10-01

Trial completed

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

Myelodysplastic Syndromes (MDS)

685 trials monitored

See 40 trials at risk

The purpose of this study is to understand the treatment patterns and clinical outcomes of myelodysplastic syndromes patients treated with luspatercept or erythropoiesis-stimulating agents

Trial Details

NCT Number	NCT06971185
Lead Sponsor	Bristol-Myers Squibb
Conditions	Myelodysplastic Syndromes (MDS)
Enrollment	430 participants
Start Date	2024-11-22
Primary Completion	2025-08-01 (estimated)
Study Completion	2025-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-30